Live Chat
Today's Hours: 8:00am - 6:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    John J. Nagelhout, Karen L. Plaus.
    Summary: A practical reference for the clinical setting, Handbook of Anesthesia, 5th Edition puts key information at your fingertips. It's an ideal companion to Nurse Anesthesia, providing easy-access coverage of the subjects you look up most frequently, such as common diseases, common procedures, drugs, and protocols. It also includes the most current information related to perioperative management and anesthetic care considerations for a wide variety of surgical procedures. Written by leading CRNA experts John Nagelhout and Karen Plaus, this compact handbook provides the up-to-date clinical and drug information you'll use in daily practice.

    Contents:
    pt. 1. Common diseases. Section 1. Cardiovascular System. Cardiomyopathy ; Coronary Artery Disease ; Heart Failure ; Hypertension ; Myocardial Infarction ; Pericardial Disease ; Peripheral Vascular Disease ; Shock ; Valvular Heart Disease
    Section 2. Central Nervous System. Alzheimer's Disease/Dementia ; Autonomic Hypereflexia/Dysautonomia ; Cerebrovascular Disease ; Guillain-Barre Syndrome ; Hydrocephalus ; Intracranial Hypertension ; Mental Disorder ; Multiple Sclerosis ; Neuropathy/Myopathy ; Parkinson's Disease ; Seizures Spinal Cord Injury
    Section 3. Endocrine System. Acromegaly ; Adrenocortical Insufficiency ; Cushing's Disease ; Diabetes Insipidus ; Diabetes Mellitus ; Hyperaldosteronism ; Hypoaldosteronism ; Hyperparathyroidism ; Hypoparathyroidism ; Hyperthyroidism ; Hypothyroidism ; Pheochromocytoma
    Section 4. Gastrointestinal System. Carcinoid Tumors and Carcinoid Syndrome ; Gallstone/Gallbladder Disease ; Hiatal Hernia/Gastric Reflux ; Inflammatory Bowel Disease ; Pancreatitis ; Splenic Disorders
    Section 5. Hematologic System. AID/HIV Infection ; Anemia ; Disseminating Intravascular Coagulation ; Hemophilia ; Heparin Induced Thromocytopenia ; Leukemia ; Polycythemia Vera ; Sickle Cell Disease ; Thalassemia ; Von Willebrand Disease
    Section 6. Hepatic System. Cirrhosis/Portal Hypertension ; Hepatic Failure ; Hepatitis
    Section 7. Musculoskeletal System. Ankylosing Spondylitis ; Kyphoscoliosis ; Lambert-Eaton ; Myasthenic Syndrome ; Malignant Hyperthermia ; Muscular Dystrophy ; Myasthenia Gravis ; Myotonic Dystrophy ; Pectus Deformities ; Rheumatoid Arthritis
    Section 8. Renal System. Acute Renal Failure ; Chronic Renal Failure ; Urolithiasis
    Section 9. Respiratory System. Adult Respiratory Distress Syndrome ; Aspiration Pneumonia ; Asthma ; Chronic Obstructive Pulmonary Disease ; Cor Pulmonale ; Cystic Fibrosis ; Pneumothorax and Hemothorax ; Pulmonary Arterial Hypertension ; Pulmonary Edema ; Pulmonary Embolism ; Restrictive Pulmonary Diseases ; Tuberculosis
    Section 10. Other Conditions. Allergic Reactions and Hypersensitivity ; Geriatrics ; Glaucoma/Open Globe ; Malnutrition ; Obesity ; Scleroderma ; Systemic Lupus Erythematosus
    pt. 2. Common Procedures. Section 1. Cardiovascular System
    Section 2. Gastrointestinal System
    Section 3. Genitourinary System
    Section 4. Head and Neck
    Section 5. Intrathoracic and Extrathoracic
    Section 6. Neurologic System
    Section 7. Neuroskeletal System
    Section 8. Obstetrics and Gynecology
    Section 9. Orthopedics and Podiatry
    Section 10. Other Procedures
    Section 11. Pediatrics
    Section 12. Neonatal Anesthetic Considerations
    Section 13. Anesthesia for Therapeutic and Diagnostic Procedures
    Section 14. Vascular Surgery
    Section 15. Complications
    pt. 3. Drugs. Appendices. Antibiotics ; Antithrombotic Drugs ; Corticosteroid Replacement ; Diabetic Drugs ; Hematology ; Immunosuppressive Drugs ; Pediatric Considerations ; Preoperative Laboratory Tests ; Pulmonary Function Test Values.
    Digital Access ClinicalKey Nursing 2014
  • Article
    Phillips CI, Gore SM, Gunn PM.
    Br J Ophthalmol. 1978 May;62(5):296-301.
    In a 1-day, 1-dose, double-masked, randomised trial, with each of 12 patients acting as his/her own control, atenolol drops 4% (a selective beta1-adrenergic blocker) produced a significantly greater fall in ocular tension measured by applanation than did adrenaline drops 1% (P is less than 0.01 Wilcoxon matched pairs signed ranks test). The mean differences, which favoured atenolol, between the falls in pressure produced by these 2 drugs at 1.5 hours, 3.5 hours, 5.5 hours, and 7 hours after instillation of the drops was 2.1, 4.6, 4.0, and 3.6 mmHg, respectively. Long-term studies would be required before any conclusion was justified about the relative merits of these 2 drugs in the treatment of glaucoma. There was no significant difference between the ocular hypotensive effects of atenolol-then-adrenaline and adrenaline-then-atenolol. It was disappointing that the expected adjuvant effect of atenolol's preceding adrenaline was not found-rather the reverse. Atenolol alone, however, was significantly better than atenolol-then-adrenaline (P is less than 0.02 Wilcoxon matched pairs signed ranks test), and there was also some indication that it was superior to adrenaline-then-atenolol. The response to adrenaline did not differ markedly from the response to the combination in either order.
    Digital Access Access Options